Instituto de Investigación Sanitaria La Fe-ko ikertzaileekin lankidetzan egindako argitalpenak (81)

2024

  1. AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action

    Science advances, Vol. 10, Núm. 41, pp. eadn6525

  2. Cerebroprotective Effects of the TLR4-Binding DNA Aptamer ApTOLL in a Rat Model of Ischemic Stroke and Thrombectomy Recanalization

    Pharmaceutics, Vol. 16, Núm. 6

  3. Msi2 enhances muscle dysfunction in a myotonic dystrophy type 1 mouse model

    Biomedical Journal, Vol. 47, Núm. 4

  4. Therapeutic potential of oleic acid supplementation in myotonic dystrophy muscle cell models

    Biological Research, Vol. 57, Núm. 1

  5. Unraveling new players in helminth pathology: extracellular vesicles from Fasciola hepatica and Dicrocoelium dendriticum exert different effects on hepatic stellate cells and hepatocytes

    International Journal for Parasitology, Vol. 54, Núm. 12, pp. 617-634

  6. Wolbachia Infection through Hybridization to Enhance an Incompatible Insect Technique-Based Suppression of Aedes albopictus in Eastern Spain

    Insects, Vol. 15, Núm. 3

2023

  1. Bull Sperm SWATH-MS-Based Proteomics Reveals Link between High Fertility and Energy Production, Motility Structures, and Sperm-Oocyte Interaction

    Journal of Proteome Research, Vol. 22, Núm. 11, pp. 3607-3624

  2. CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2

    Molecular Therapy - Nucleic Acids, Vol. 31, pp. 324-338

  3. Effect and mechanisms of resveratrol in animal models of ischemic stroke: A systematic review and Bayesian meta-analysis

    Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 12, pp. 2013-2028

  4. Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain

    Movement Disorders Clinical Practice, Vol. 10, Núm. 6, pp. 992-997

2022

  1. An ultra-sensitive homologous chemiluminescence immunoassay to tackle penicillin allergy

    Analytica Chimica Acta, Vol. 1214

  2. Brain Cell Senescence: A New Therapeutic Target for the Acute Treatment of Ischemic Stroke

    Journal of neuropathology and experimental neurology, Vol. 81, Núm. 8, pp. 614-620

  3. Ensembles of endothelial and mural cells promote angiogenesis in prenatal human brain

    Cell, Vol. 185, Núm. 20, pp. 3753-3769.e18

  4. Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain

    Microorganisms, Vol. 10, Núm. 4

  5. Evaluation of the Immunomodulatory Effect of the Recombinant 14-3-3 and Major Antigen Proteins of Strongyloides stercoralis against an Infection by S. venezuelensis

    Vaccines, Vol. 10, Núm. 8

  6. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 279-284

  7. Intravenous SPION-labeled adipocyte-derived stem cells targeted to the brain by magnetic attraction in a rat stroke model: An ultrastructural insight into cell fate within the brain

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 39

  8. Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency

    Cells, Vol. 11, Núm. 3

  9. Nests of dividing neuroblasts sustain interneuron production for the developing human brain

    Science, Vol. 375, Núm. 6579

2021

  1. Co-administration of human MSC overexpressing HIF-1α increases human CD34+ cell engraftment in vivo

    Stem Cell Research and Therapy, Vol. 12, Núm. 1